Physician Resources: BKV, CMV and EBV (PTLD): Bench to Bedside Updates
Upon completion of this activity, participants should be able to:
- Describe diagnostic testing for antiviral resistant CMV infection in kidney transplantation
- Recognize the role of Letermovir for prevention and treatment of CMV in kidney transplantation
- Identify risk factors and approaches to BKV infection in kidney transplantation
Chethan Puttarajappa, MD, Internal Medicine
Dr. Chethan Puttarajappa has reported no relevant relationships with entities producing health care goods or services.
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits ™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.10) continuing education units (CEU) which are equivalent to 1.00 contact hour.
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 Attendance